Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aqueous Phase Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101735144A details a solvent-free synthesis of isonicotinoyl azide. Achieve 97% yield and reduced lead time for high-purity agrochemical intermediates.
Novel aqueous-phase synthesis reduces solvent waste and cost. Reliable supply of high-purity Solifenacin intermediate for global pharmaceutical manufacturing.
Novel water-based method for antipsychotic API intermediate Iloperidone offers high purity and reduced environmental impact compared to traditional DMF processes.
Patent CN1740145A details a green aqueous synthesis for cinnamamide compounds. Discover cost reduction in pharmaceutical intermediate manufacturing and high-purity scalable routes.
Patent CN108752328B reveals a water-based Azilsartan synthesis route offering high purity and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Patent CN111995607A details a novel aqueous synthesis for phenyl selenized luteolin and quercetin, offering scalable antiviral intermediate production with reduced costs.
Patent CN104860915B reveals water-based synthesis for 4H-4-arylbenzopyran intermediates. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable green chemistry.
Patent CN102731357B details a water-based synthesis for N,N'-dicyclohexylthiourea, offering >99% yield and eliminating toxic organic solvents for safer API manufacturing.
Patent CN110590759A details aqueous DBSA catalysis for high-purity asymmetric bisindole compounds offering green manufacturing and supply chain stability for global pharmaceutical partners.
Patent CN1781915A reveals a high-yield, safe process for oxazolylethanol derivatives, replacing hazardous reagents with aqueous systems for cost-effective API manufacturing.
Patent CN1553908A details a breakthrough water-based process for cilostazol, offering high purity and yield while eliminating hazardous organic solvents for cost-effective manufacturing.
Patent CN1166649C reveals an aqueous synthesis route for Gadoteridol intermediates, offering safer manufacturing and reduced environmental impact for pharmaceutical supply chains.
Patent CN100412058C reveals a green synthesis route for bis-indole derivatives using Meldrum's acid in water, offering significant cost and supply chain advantages for pharmaceutical intermediate manufacturers.
Patent CN114436930A reveals water-based synthesis for Boc-L-hydroxyproline. Achieves 99.9% purity, eliminates organic solvents, ensures supply chain stability.
Patent CN112574092B reveals a green aqueous method for high-purity indole derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN1265092A details a continuous aqueous process for L-carnitine using (S)-3-activated hydroxybutyrolactone, offering high purity and cost efficiency.
Advanced one-pot synthesis of quinazolinone derivatives using aqueous copper catalysis. Discover cost-effective manufacturing and high-purity supply chain solutions.
Analysis of patent CN1243001C reveals a scalable aqueous synthesis route for Sertindole intermediates, offering significant cost reduction and environmental compliance advantages for pharmaceutical supply chains.
Patent CN102408392A details a green aqueous synthesis for 2-(N,N-disubstituted amino)-4-thiazolinone. This method offers high yields, reduced costs, and scalable production for pharma intermediates.
Patent CN103613521A details a water-phase synthesis for Probenecid. This method eliminates heavy metals and organic solvents, offering significant supply chain and cost advantages.